Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001088875-11-000006
Filing Date
2011-01-25
Accepted
2011-01-25 11:29:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 protalixbio12312010.txt SC 13G 9797
  Complete submission text file 0001088875-11-000006.txt   11939
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-50118 | Film No.: 11545535
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address CALTON SQUARE 1GREENSIDE ROW EDINBURGH X0 EH1 3AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EHI 3AN 011441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: SC 13G